Author:
Espinar Francisco Javier Otero,Lavilla Carlos Bendicho,Fernández Guillermo Blanco,Tomé Victoria Díaz,Otero Xurxo García
Reference153 articles.
1. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm Res,1995
2. Committee for Medicinal Products for Human Use. ICH M9 guideline on biopharmaceutics classification system-based biowaivers; 2018.
3. U.S. Department of Health and Human Services Food and Drug Administration. M9 Biopharmaceutics Classification System- based biowaivers guidance for industry; 2021.
4. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC;Tsume;Eur J Pharm Sci [Internet],2014
5. Quantitative Biopharmaceutics Classification System: the central role of dose/solubility ratio;Rinaki;Pharm Res [Internet],2003